Delta-Fly Pharma, Inc. (TYO:4598)

Delta-Fly Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 13, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,724	5,595	6,929	6,560	6,937	7,340
Market Cap Growth	-46.88%	-19.26%	5.62%	-5.43%	-5.49%	108.63%
Enterprise Value	2,484	4,857	5,202	5,763	5,596	6,061
Last Close Price	224.00	575.00	842.00	1030.00	1280.00	1385.00
PS Ratio	-	-	-	-	23.12	24.47
PB Ratio	13.22	20.27	5.63	8.30	5.63	3.53
P/TBV Ratio	13.22	20.27	5.63	8.30	5.63	3.53
EV/Sales Ratio	-	-	-	-	18.65	20.20
Net Debt / Equity Ratio	-1.16	-1.23	-1.15	-1.07	-1.03	-1.00
Net Debt / EBITDA Ratio	0.15	0.20	1.01	0.64	1.32	2.46
Net Debt / FCF Ratio	-	0.18	1.11	0.65	1.35	2.88
Asset Turnover	-	-	-	-	0.17	0.14
Quick Ratio	2.35	2.49	5.88	7.34	13.93	25.46
Current Ratio	2.41	2.53	5.94	7.53	14.07	25.79
Return on Equity (ROE)	-370.98%	-228.40%	-141.41%	-131.35%	-58.43%	-41.70%
Return on Assets (ROA)	-179.39%	-111.90%	-73.69%	-73.71%	-34.47%	-24.64%
Return on Invested Capital (ROIC)	-	-	-	-	-	-1577.78%
Return on Capital Employed (ROCE)	-796.60%	-614.40%	-113.80%	-166.20%	-77.90%	-41.00%
Earnings Yield	-61.02%	-30.76%	-20.62%	-20.24%	-13.94%	-11.74%
FCF Yield	-	-32.78%	-18.47%	-19.86%	-13.55%	-9.89%
Buyback Yield / Dilution	-29.12%	-22.38%	-26.91%	-4.61%	-17.64%	-3.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.